NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cancer Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Angiogenesis



Findings from Vanderbilt University in angiogenesis reported



February 10th, 2009

"The transcription factor nuclear factor-kappa B (NF-kappa B) is constitutively activated in many types of cancers and has been implicated in gene expression important for angiogenesis, tumor growth, progression, and metastasis. Here, we show that the NF-kappa B activator, I kappa B kinase-alpha (IKK alpha), but not IKK beta, promotes endothelial cell motility and tumor angiogenesis," scientists in the United States report.

"IKK alpha is elevated in tumor vasculature compared with normal endothelium. Overexpression of IKK alpha in endothelial cells promoted cell motility and vascular tubule formation in a three-dimensional culture assay, and conversely, knockdown of IKK...


Source: Cancer Weekly (2009-02-10)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login